TNXP · Categories · Form 5
TNXP - SEC Form 5 annual insider statements
Tonix Pharmaceuticals Holding Corp. (TNXP) sec form 5 annual insider statements - real-time wire coverage filtered to Form 5 only.
Recent Form 5 for TNXP
- Saenger Bradley was granted 701 shares (SEC Form 5)5 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
- SEC Form 5: Saenger Bradley was granted 18,248 shares, increasing direct ownership by 1,306% to 19,645 units5 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
- SEC Form 5: Sullivan Gregory M was granted 36,496 shares, increasing direct ownership by 58% to 99,223 units5 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)
- SEC Form 5: Bradley Saenger was granted 493 units of Common Stock, increasing ownership by 55% to 1,397 units5 - Tonix Pharmaceuticals Holding Corp. (0001430306) (Issuer)